Delivery Order SPE2DB20D3103-SPE2DB25FP6R6
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,039.16 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. This firm fixed-price delivery order, which is not set-aside, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. This competitive award, valued at $1,100.24 with a firm fixed price structure, represents a non-set-aside contract and is scheduled for completion by August 19, 2025. The product will be delivered to the Conshohocken, Pennsylvania...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $6,033.03. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 9, 2025. The performance location is listed as the vendor's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,013.50 for Ondansetron Orally Disintegrating Tablets 8mg (30-count supply) on August 21, 2025, with completion targeted for September 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for Ondansetron ODT 4 mg tablets (30-count supply) with a contract ceiling value of $15,578.02. This firm fixed price delivery order, which is not set-aside for any socioeconomic category, is expected to be completed by July 25, 2025, and will be performed at the contractor's Conshohocken, PA location....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $2,872.80 by the Department of Defense Medical Supply Chain on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation. This award is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,795.50, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 28, 2025. The award was executed under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $13,637.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $14,466.96 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $7,069.80 and an ultimate completion date of July 23, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. Performance will be executed from the contractor's location in Conshohocken,...